Diego Centonze is Full Professor of Neurology at Tor Vergata University, Rome, Italy and Director of the Neurology Unit at the IRCSS Istituto Neurologico Mediterraneo Neuromed, Pozzilli (IS), Italy. He also leads the Experimental Neurology Laboratory at Tor Vergata University. His major clinical interest involves the evaluation of new drugs for the treatment of MS. His research interests are related to the role of synaptic transmission and plasticity in the pathophysiology of MS and its experimental model, as well as to the physiology of the endocannabinoid system and its involvement in inflammatory neurodegenerative diseases. Prof. Centonze graduated in Medicine at the University of Rome La Sapienza in 1994, specialised in Neurology in 1999 and in Psychiatry in 2006 at the University of Rome Tor Vergata. He obtained his PhD in Rehabilitation Medicine in 2012. He is Principal Investigator of many phase II, III and IV national and international trials with new therapeutic agents for MS and is a member of the Society for Neuroscience, the Italian Neurological Society (SIN) and the Italian Neuroscience Society (SINS). Prof. Centonze is author of around 300 peer- reviewed papers published in international journals of Neuroscience, Neurology and Psychiatry.